Amgen AMGN
NASDAQ AMGN
$447.28 +8.94 (+2.04%)
At close: Oct 22, 2026 · 4:00 PM EDT

Amgen (AMGN) Convertible Debt (2009 - 2010)

Updated

Amgen (AMGN) reported Convertible Debt of $2.2 billion for Q1 2010, down 51.2% from the prior quarter.

Analysis

Amgen (AMGN) Convertible Debt (2009 - 2010) Analysis & Trends

At the end of FY2009, Amgen posted Convertible Debt of $4.51 billion.

  • Per Business Quant data, the three quarters before Q1 2010 came in at $4.51 billion (Q4 2009), $4.45 billion (Q3 2009) and $4.38 billion (Q2 2009).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Vertex Pharmaceuticals 135.58 Bn 107.59 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2010 2.20 Bn
Dec 31, 2009 4.51 Bn
Sep 30, 2009 4.45 Bn
Jun 30, 2009 4.38 Bn
API Access

Amgen Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=AMGN&period=max&api_key=YOUR_API_KEY